Status of selenium in prostate cancer prevention

British Journal of Cancer

Volumn 91, Issue 2, 2004, Pages 195-199

  Combs Jr , G F ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Apoptosis; Carcinogenesis; Cell cycle; Methylselenol; Prostate; Selenium; Selenomethionine

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SELENIUM;

APOPTOSIS; BLOOD LEVEL; CANCER CELL CULTURE; CANCER PREVENTION; CANCER RISK; CELL TRANSPORT; CLINICAL TRIAL; COLORECTAL CANCER; DIET SUPPLEMENTATION; DOSE CALCULATION; DRUG MECHANISM; FOOD ANALYSIS; HUMAN; MALE; MINERAL METABOLISM; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RISK REDUCTION; SHORT SURVEY; TUMOR VASCULARIZATION;

EID: 3843122169     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601974     Document Type: Short Survey

References (47)

1. Arnold WN, Thrasher JB (2003) Selenium concentration in the prostate. Biol Trace Element Res 91: 277-280
2. Bhamre S, Whitin JC, Cohen HJ (2003) Selenomethionine does not affect PSA secretion independent of its effect on LNCaP cell growth. Prostate 54: 315-321
3. Brooks JD, Metter EJ, Chow DW, Sokoll LJ, Landi P, Nelson WG, Muller D, Andres R, Carter HB (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166: 2034-2038
4. Clark LC, Combs Jr GF, Turnbull BW, Slate E, Alberts D, Abele D, Allison R, Bradshaw J, Chalker D, Chow J, Curtis D, Dalen J, Davis L, Deal R, Dellasega M, Glover R, Graham G, Gross E, Hendrix J, Herlong J, Knight F, Krongrad A, Lesher J, Moore J, Park K, Rice J, Rogers A, Sanders B, Schurman B, Smith C, Smith E, Taylor J, Woodward J (1996) The nutritional prevention of cancer with selenium 1983-1993: a randomized clinical trial. J Am Med Assoc 276: 1957-1963
5. Combs Jr GF, Gray WP (1998) Chemopreventive agents: selenium. Pharm Exp Ther 79: 179-192
6. Combs Jr GF, Lü J (2001) Selenium as a cancer preventive agent. In Selenium: Molecular Biology and Role in Health, Hatfield D (ed). pp 205-217, New York: Kluwer Academic Publishers
7. Corcoran NM, Najdovska M, Costello AJ (2004) Inorganic selenium retards progression of experimental hormone refractory prostate cancer. J Urol 171: 907-910
8. Dong Y, Ip C, Ganther H (2002) Evidence of a field effect associated with mammary cancer prevention by methylselenic acid. Anticancer Res 22: 27-32
9. Dong Y, Lee SO, Zhang H, Marshall J, Gao AC, Ip C (2004) Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signalling. Cancer Res 64: 19-20
10. Dong Y, Zhang H, Hawthorn L, Ganther HE, Ip C (2003) Delineation of the molecular basis for selenium-induced growth arrest in human prostatic cancer cells by oligonucleotide array. Cancer Res 63: 52-59
11. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Combs Jr GF, Slate EH, Marshall JR, Clark LC (2003a) Selenium supplementation, baseline plasma selenium status, and influence on prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. Br J Urol 91: 608-612
12. Duffield-Lillico AJ, Reid ME, Turnbull, Combs Jr GF, Slate EH, Fischbach LA, Marshall JR, Clark LC (2002) Baseline characteristics and the effect of selenium supplementation on cancer risk in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 11: 630-639
13. Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs Jr GF, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC (2003b) Selenium supplementation and secondary prevention of non-melanoma skin cancer in a randomized trial. J Natl Cancer Inst 95: 1477-1481
14. Gasparian AV, Yao YJ, Lu J, Yemelyanov AY, Lyakh LA, Slaga TJ, Budunova IV (2002) Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells. Mol Cancer Ther 1: 1079-1087
15. Gianduzzo TR, Holmes EG, Tinggi U, Shahin M, Mactaggart P, Nicol D (2003) Prostatic and peripheral blood selenium levels after oral supplementation. J Urol 170: 870-873
16. Ip C, Birringer M, Block E, Kotrebai M, Tyson JF, Uden PC, Lisk DJ (2000b) Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J Agric Food Chem 48: 4452-4459
17. Ip C, Dong Y (2001) Methylselenocysteine modulates cell proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Anticancer Res 21: 863-867
18. Ip C, Dong Y, Ganther HE (2002) New concepts in selenium chemoprevention. Cancer Metast Rev 21: 281-289
19. Ip C, Ganther HE (1990) Activity of methylated forms of selenium in cancer prevention. Cancer Res 50: 1206-1211
20. Ip C, Ganther HE (1991) Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis 12: 365-367
21. Ip C, Ganther HE (1992a) Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis 13: 1167-1170
22. Ip C, Ganther HE (1992b) Biological activities of trimethylselenonium as influenced by arsenite. J Inorgan Biochem 46: 215-222
23. Ip C, Hayes C, Budnick RM, Ganther HE (1991) Chemical form or selenium, critical metabolites, and cancer prevention. Cancer Res 51: 595-600
24. Ip C, Thompson HJ, Shu Z, Ganther HE (2000a) In vitro and in vito studies of methylselenic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res 60: 2882-2886
25. Jiang C, Jiang W, Ip C, Ganther HE, Lu J (1999) Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinogen 26: 213-215
26. Jiang C, Wang Z, Ganther H, Lu J (2002) Distinct effects of methylselenic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol Cancer Ther 1: 1059-1066
27. Kaeck M, Lü J, Strange R, Ip C, Ganther HE, Thompson HJ (1997) Differential induction of growth arrest inducible genes by selenium compounds. Biochem Pharmacol 53: 921-926
28. Korotkov KV, Kumaraswamy E, Zhou Y, Hatfield DL, Gladyshev VN (2001) Association between the 15-kDa selenoprotein and UDP-glucose:glycoprotein glucosyltransferase in the endoplasmis reticulum of mammalian cells. J Biol Chem 276: 15330-15336
29. Lü J, Jiang C, Kaeck M, Ganther H, Vadhanavikit S, Ip C, Thompson H (1995) Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol 50: 213-219
30. Lü J, Kaeck M Jiang C, Wilson AC, Thompson HJ (1994) Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol 47: 1531-1535
31. Lü J, Pei J, Ip C, Lisk DJ, Ganther HE, Thompson HJ (1996) Effect on an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis 17: 1903-1907
32. Medina D, Thompson H, Ganther H, Ip C (2001) Se-methylselenocysteine: a new compound for chemoprevention of breast cancer. Nutr Cancer 40: 12-17
33. Niskar AS, Paschal DC, Kieszak SM, Flegal KM, Bowman B, Gunther EW, Pike JJ, Rubin C, Sampson EJ, McGeehin M (2003) Serum selenium levels in the US population. Biol Trace Element Res 91: 1-10
34. Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BBW, Clark LC, Marshall JR (2002) Selenium supplementation and lung cancer incidence: an update on the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 11: 1285-1291
35. Rudolph RE, Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipaeu PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BI (2003) Serum selenium in relation to markers of neoplastic progression among persons with Barrett's esophagus. J Natl Cancer Inst 95: 750-757
36. Sinha R, Kilev SC, Lu J, Moraes R, Thompson HJ, Jaken S, Medina D (1999) Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. Cancer Lett 146: 135-145
37. Sinha R, Medina D (1997) Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. Carcinogenesis 18: 1541-1547
38. Vadhanavikit S, Ip C, Ganther HE (1993) Metabolites of sodium selenite and methylated selenium compounds administered at cancer prevention levels in the rat. Xenobiotica 23: 731-745
39. Van den Brandt PA, Zeegers MP, Bode P, Goldbohm RA (2003) Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 12: 866-871
40. Venkateswaran V, Klotz LH, Fleshner NE (2002) Selenium modulation of csll proliferation and cell cycle biomarkers in human prostate carcinoma cell lines. Cancer Res 62: 2540-2545
41. Vinceti M, Malagoli C, Bergomi M, Vivolvi G (2003) Correspondence re: Duffield-Lillico et al Baseline characteristics and effects of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutrition al prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 12: 77
42. Vogt TM, Ziegler RG, Graubard BI, Swanson CA, Greenberg RS, Schoenberg JB, Hayes GM, Mayne ST (2003) Serum selenium and risk of prostate cancer in US blacks and whites. Int J Cancer Res 103: 664-670
43. Wang Z, Jiang C, Lu J (2002) Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol. Mol Carcinogen 34: 113-120
44. Waters DJ, Shen S, Cooley DM, Bostwick DG, Quian J, Combs Jr GF, Glickman LT, Oteham C, Schlittler D, Morris IS (2003) Dietary selenium supplementation reduced the extent of DNA damage and upregulated apoptosis within the aging prostate. J Natl Cancer Inst 95: 237-241
45. Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, Giovannucci E (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90: 1219-1224
46. Zhu Z, Kimura M, Itokawa Y, Aoki T, Takahasi JA, Nakatsu S, Oda Y, Kikuchi H (1996) Apoptosis induced by selenium in human glioma cell lines. Biol Trace Element Res 54: 123-134
47. Zu K, Ip C (2003) Synergy between selenium and vitamin E in apoptosis induction is associated with activation of initiator caspases in human prostate cancer cells. Cancer Res 63: 6988-6995